BioSpace News Archive

Psoriasis Drugs Market is Expected To Reach USD 42.12 Billion By 2028 at a CAGR of 9.30%

Changing lifestyle, rising awareness about the condition, and advancements in genetic medicine have resulted in boosting the Psoriasis Drugs market.

September 14, 2022
·
7 min read
Drug Infusion Systems Market Size to Reach Valuation of USD 18.17 Billion in 2028

The global drug infusion systems market size reached USD 10.56 Billion in 2020 and is expected to register a CAGR of 7.1%, during the forecast period, according to latest analysis by Emergen Research.

September 14, 2022
·
13 min read
Compound Management Market Size Worth USD 826.2 Million in 2028

The global compound management market size is expected to reach USD 826.2 Million in 2028 at a steady CAGR, according to latest analysis by Emergen Research.

September 14, 2022
·
6 min read
BioMidwest

Independent Research Finds Underlying Method for C2N’s p-Tau217 Ratio Blood Test Outperforms Other Tau Blood Tests Used for Alzheimer’s Diagnoses

A group of distinguished Alzheimer’s disease researchers has affirmed, in a new study published online in the journal Brain, the superiority of the methods that are the basis of C2N Diagnostics’ new p[hospho]-tau217 ratio test.

September 14, 2022
·
4 min read
Business

On Demand Pharmaceuticals and Wavelength Pharmaceuticals Awarded BIRD Foundation Grant

On Demand Pharmaceuticals, Inc. (ODP), and Wavelength Pharmaceuticals ( Petah Tikva , Israel ) - a SEQENS company, are pleased to announce that the US-Israel Binational Industrial Research & Development (BIRD) Foundation grant.

September 14, 2022
·
3 min read
Research from the University of Birmingham, U.K., identifies new treatment target for CNS injury and neurological disease

Birmingham researchers have identified a potential target for drugs to treat long-term neurological conditions like Alzheimer’s Disease and foster nerve regeneration in central nervous system injuries.

September 14, 2022
·
4 min read
Business

Hemostemix Announces the Appointment of Dr. Renzo Cecere, MD, FRCSC to Its Scientific Advisory Board

Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (“Hemostemix” or the “Company”) is pleased to announce the appointment of Dr. Renzo Cecere, MD, FRCSC, to its Scientific Advisory Board.

September 14, 2022
·
7 min read
Biotech Bay

Codexis’ 2022 Protein Engineering Forum Showcases Recent Industry Success and Emerging Innovations in the Field

Codexis, Inc., a leading enzyme engineering company enabling the promise of synthetic biology, announced the recent hosting of its in-person Protein Engineering Forum from September 12-13, 2022 in San Francisco, California.

September 14, 2022
·
2 min read
Business

Neuron23 and QIAGEN Announce Collaboration to Develop the First Next-Generation Sequencing Companion Diagnostic for Novel Parkinson’s Disease Drug

Neuron23™ Inc. and QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a collaboration to develop a companion diagnostic for Neuron23’s LRRK2 inhibitor for Parkinson’s disease.

September 14, 2022
·
7 min read
Deals

Rockwell Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Rockwell Medical, Inc. today announced that the Compensation Committee of the Company’s Board of Directors approved the grant of stock options to purchase an aggregate of 66,000 shares of the Company’s common stock.

September 14, 2022
·
2 min read